The stock of MBAC Fertilizer Corp (CVE:MBC) reached all time low today, Nov, 9 and still has $1.32 target or 12.00% below today’s $1.50 share price. This indicates more downside for the $2.72M company. This technical setup was reported by Barchart.com. If the $1.32 PT is reached, the company will be worth $326,400 less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. About 11,605 shares traded hands. MBAC Fertilizer Corp (CVE:MBC) has risen 6.00% since October 10, 2016 and is uptrending. It has outperformed by 1.22% the S&P500.
More notable recent MBAC Fertilizer Corp (CVE:MBC) news were published by: Marketwatch.com which released: “TSX Delisting Review – MBAC Fertilizer Corp. (symbol:MBC MBC.WT)” on April 06, 2016, also Marketwatch.com with their article: “TSX Delisting Review – MBAC Fertilizer Corp. (symbol:MBC and MBC.WT)” published on June 24, 2016, Reuters.com published: “BRIEF-MBAC Fertilizer announces filing under companies’ creditors arrangem…” on August 04, 2016. More interesting news about MBAC Fertilizer Corp (CVE:MBC) were released by: Marketwired.com and their article: “MBAC Fertilizer Reports Q1, 2016 Results” published on June 03, 2016 as well as Marketwired.com‘s news article titled: “MBAC Fertilizer Reports FY2015 Results” with publication date: April 28, 2016.
MBAC Fertilizer Corp. is a Canada-based company, which is engaged in the mining, production and exploration of phosphate fertilizers in the Brazilian market. The company has a market cap of $2.72 million. The Firm operates the Itafos Arraias Single Super Phosphate Operations. It currently has negative earnings. The Company’s divisions include Operations, Development and Exploration, and Corporate.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.